The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Multiplexed Diagnostics-Global Market Insights and Sales Trends 2024
Synopsis
The key to multiplexing is miniaturization. Instead of having just one assay in a well a whole array of miniaturized, spotted assays is analyzed simultaneously. Combining several tests brings significant savings in time and money.
The global Multiplexed Diagnostics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Multiplexed Diagnostics in various end use industries. The expanding demands from the Academic Research Institutes, Hospital, Pharmaceutical Companies and Clinical Research Organizations, are propelling Multiplexed Diagnostics market. Very High Density Multiplexed Assays (Above 10,000-plex), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the High Density Multiplexed Assays (500 Below plex Below 10,000) segment is estimated at % CAGR for the next seven-year period.
The growth of private and public funding in the fields of genomics and personalized medicineis currently a high value driver for the global multiplexed diagnostics market. It is boosting the demand for advanced diagnostic technologies for precision-based diagnostics of life-threatening diseases. Current positive trends in the global multiplexed diagnostics market include the increasing rate of extensive research and development efforts being made to expand and diversify the existing applications in multiplexed diagnostics, the development in generic platforms, and a greater use of multiplexed diagnostics in academic and research organizations.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Multiplexed Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Multiplexed Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Multiplexed Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Multiplexed Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Multiplexed Diagnostics covered in this report include Agilent Technologies, Bio-Rad Laboratories, BioMerieux, F. Hoffmann-La Roche, Illumina, Luminex, Hologic, Thermo Fisher Scientific and Siemens Healthineers, etc.
The global Multiplexed Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Agilent Technologies
Bio-Rad Laboratories
BioMerieux
F. Hoffmann-La Roche
Illumina
Luminex
Hologic
Thermo Fisher Scientific
Siemens Healthineers
Abbott Laboratories
Global Multiplexed Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Multiplexed Diagnostics market, Segment by Type:
Very High Density Multiplexed Assays (Above 10,000-plex)
High Density Multiplexed Assays (500 Below plex Below 10,000)
Medium Density Multiplexed Assays (plex Below 500)
Low Density Multiplexed Assays (plex Below 5)
Next Generation Sequencing Assays
Global Multiplexed Diagnostics market, by Application
Academic Research Institutes
Hospital
Pharmaceutical Companies
Clinical Research Organizations
Diagnostic Laboratories
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Multiplexed Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The key to multiplexing is miniaturization. Instead of having just one assay in a well a whole array of miniaturized, spotted assays is analyzed simultaneously. Combining several tests brings significant savings in time and money.
The global Multiplexed Diagnostics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Multiplexed Diagnostics in various end use industries. The expanding demands from the Academic Research Institutes, Hospital, Pharmaceutical Companies and Clinical Research Organizations, are propelling Multiplexed Diagnostics market. Very High Density Multiplexed Assays (Above 10,000-plex), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the High Density Multiplexed Assays (500 Below plex Below 10,000) segment is estimated at % CAGR for the next seven-year period.
The growth of private and public funding in the fields of genomics and personalized medicineis currently a high value driver for the global multiplexed diagnostics market. It is boosting the demand for advanced diagnostic technologies for precision-based diagnostics of life-threatening diseases. Current positive trends in the global multiplexed diagnostics market include the increasing rate of extensive research and development efforts being made to expand and diversify the existing applications in multiplexed diagnostics, the development in generic platforms, and a greater use of multiplexed diagnostics in academic and research organizations.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Multiplexed Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Multiplexed Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Multiplexed Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Multiplexed Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Multiplexed Diagnostics covered in this report include Agilent Technologies, Bio-Rad Laboratories, BioMerieux, F. Hoffmann-La Roche, Illumina, Luminex, Hologic, Thermo Fisher Scientific and Siemens Healthineers, etc.
The global Multiplexed Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Agilent Technologies
Bio-Rad Laboratories
BioMerieux
F. Hoffmann-La Roche
Illumina
Luminex
Hologic
Thermo Fisher Scientific
Siemens Healthineers
Abbott Laboratories
Global Multiplexed Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Multiplexed Diagnostics market, Segment by Type:
Very High Density Multiplexed Assays (Above 10,000-plex)
High Density Multiplexed Assays (500 Below plex Below 10,000)
Medium Density Multiplexed Assays (plex Below 500)
Low Density Multiplexed Assays (plex Below 5)
Next Generation Sequencing Assays
Global Multiplexed Diagnostics market, by Application
Academic Research Institutes
Hospital
Pharmaceutical Companies
Clinical Research Organizations
Diagnostic Laboratories
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Multiplexed Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Multiplexed Diagnostics
1.1 Multiplexed Diagnostics Market Overview
1.1.1 Multiplexed Diagnostics Product Scope
1.1.2 Multiplexed Diagnostics Market Status and Outlook
1.2 Global Multiplexed Diagnostics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Multiplexed Diagnostics Market Size by Region (2018-2029)
1.4 Global Multiplexed Diagnostics Historic Market Size by Region (2018-2023)
1.5 Global Multiplexed Diagnostics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Multiplexed Diagnostics Market Size (2018-2029)
1.6.1 North America Multiplexed Diagnostics Market Size (2018-2029)
1.6.2 Europe Multiplexed Diagnostics Market Size (2018-2029)
1.6.3 Asia-Pacific Multiplexed Diagnostics Market Size (2018-2029)
1.6.4 Latin America Multiplexed Diagnostics Market Size (2018-2029)
1.6.5 Middle East & Africa Multiplexed Diagnostics Market Size (2018-2029)
2 Multiplexed Diagnostics Market by Type
2.1 Introduction
2.1.1 Very High Density Multiplexed Assays (Above 10,000-plex)
2.1.2 High Density Multiplexed Assays (500 Below plex Below 10,000)
2.1.3 Medium Density Multiplexed Assays (plex Below 500)
2.1.4 Low Density Multiplexed Assays (plex Below 5)
2.1.5 Next Generation Sequencing Assays
2.2 Global Multiplexed Diagnostics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Multiplexed Diagnostics Historic Market Size by Type (2018-2023)
2.2.2 Global Multiplexed Diagnostics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Multiplexed Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Multiplexed Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Multiplexed Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Multiplexed Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Multiplexed Diagnostics Revenue Breakdown by Type (2018-2029)
3 Multiplexed Diagnostics Market Overview by Application
3.1 Introduction
3.1.1 Academic Research Institutes
3.1.2 Hospital
3.1.3 Pharmaceutical Companies
3.1.4 Clinical Research Organizations
3.1.5 Diagnostic Laboratories
3.2 Global Multiplexed Diagnostics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Multiplexed Diagnostics Historic Market Size by Application (2018-2023)
3.2.2 Global Multiplexed Diagnostics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Multiplexed Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Multiplexed Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Multiplexed Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Multiplexed Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Multiplexed Diagnostics Revenue Breakdown by Application (2018-2029)
4 Multiplexed Diagnostics Competition Analysis by Players
4.1 Global Multiplexed Diagnostics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Multiplexed Diagnostics as of 2022)
4.3 Date of Key Players Enter into Multiplexed Diagnostics Market
4.4 Global Top Players Multiplexed Diagnostics Headquarters and Area Served
4.5 Key Players Multiplexed Diagnostics Product Solution and Service
4.6 Competitive Status
4.6.1 Multiplexed Diagnostics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Agilent Technologies
5.1.1 Agilent Technologies Profile
5.1.2 Agilent Technologies Main Business
5.1.3 Agilent Technologies Multiplexed Diagnostics Products, Services and Solutions
5.1.4 Agilent Technologies Multiplexed Diagnostics Revenue (US$ Million) & (2018-2023)
5.1.5 Agilent Technologies Recent Developments
5.2 Bio-Rad Laboratories
5.2.1 Bio-Rad Laboratories Profile
5.2.2 Bio-Rad Laboratories Main Business
5.2.3 Bio-Rad Laboratories Multiplexed Diagnostics Products, Services and Solutions
5.2.4 Bio-Rad Laboratories Multiplexed Diagnostics Revenue (US$ Million) & (2018-2023)
5.2.5 Bio-Rad Laboratories Recent Developments
5.3 BioMerieux
5.3.1 BioMerieux Profile
5.3.2 BioMerieux Main Business
5.3.3 BioMerieux Multiplexed Diagnostics Products, Services and Solutions
5.3.4 BioMerieux Multiplexed Diagnostics Revenue (US$ Million) & (2018-2023)
5.3.5 F. Hoffmann-La Roche Recent Developments
5.4 F. Hoffmann-La Roche
5.4.1 F. Hoffmann-La Roche Profile
5.4.2 F. Hoffmann-La Roche Main Business
5.4.3 F. Hoffmann-La Roche Multiplexed Diagnostics Products, Services and Solutions
5.4.4 F. Hoffmann-La Roche Multiplexed Diagnostics Revenue (US$ Million) & (2018-2023)
5.4.5 F. Hoffmann-La Roche Recent Developments
5.5 Illumina
5.5.1 Illumina Profile
5.5.2 Illumina Main Business
5.5.3 Illumina Multiplexed Diagnostics Products, Services and Solutions
5.5.4 Illumina Multiplexed Diagnostics Revenue (US$ Million) & (2018-2023)
5.5.5 Illumina Recent Developments
5.6 Luminex
5.6.1 Luminex Profile
5.6.2 Luminex Main Business
5.6.3 Luminex Multiplexed Diagnostics Products, Services and Solutions
5.6.4 Luminex Multiplexed Diagnostics Revenue (US$ Million) & (2018-2023)
5.6.5 Luminex Recent Developments
5.7 Hologic
5.7.1 Hologic Profile
5.7.2 Hologic Main Business
5.7.3 Hologic Multiplexed Diagnostics Products, Services and Solutions
5.7.4 Hologic Multiplexed Diagnostics Revenue (US$ Million) & (2018-2023)
5.7.5 Hologic Recent Developments
5.8 Thermo Fisher Scientific
5.8.1 Thermo Fisher Scientific Profile
5.8.2 Thermo Fisher Scientific Main Business
5.8.3 Thermo Fisher Scientific Multiplexed Diagnostics Products, Services and Solutions
5.8.4 Thermo Fisher Scientific Multiplexed Diagnostics Revenue (US$ Million) & (2018-2023)
5.8.5 Thermo Fisher Scientific Recent Developments
5.9 Siemens Healthineers
5.9.1 Siemens Healthineers Profile
5.9.2 Siemens Healthineers Main Business
5.9.3 Siemens Healthineers Multiplexed Diagnostics Products, Services and Solutions
5.9.4 Siemens Healthineers Multiplexed Diagnostics Revenue (US$ Million) & (2018-2023)
5.9.5 Siemens Healthineers Recent Developments
5.10 Abbott Laboratories
5.10.1 Abbott Laboratories Profile
5.10.2 Abbott Laboratories Main Business
5.10.3 Abbott Laboratories Multiplexed Diagnostics Products, Services and Solutions
5.10.4 Abbott Laboratories Multiplexed Diagnostics Revenue (US$ Million) & (2018-2023)
5.10.5 Abbott Laboratories Recent Developments
6 North America
6.1 North America Multiplexed Diagnostics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Multiplexed Diagnostics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Multiplexed Diagnostics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Multiplexed Diagnostics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Multiplexed Diagnostics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Multiplexed Diagnostics Market Dynamics
11.1 Multiplexed Diagnostics Industry Trends
11.2 Multiplexed Diagnostics Market Drivers
11.3 Multiplexed Diagnostics Market Challenges
11.4 Multiplexed Diagnostics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
